AbbVie said on Monday its treatment for a group of blood cancers failed to meet the main goal of significantly improving the ...

A programme to evaluate a blood test for early signs of pancreatic cancer has started to recruit volunteers. The Safe-D study ...

England's National Health Service said Friday it is the first health system in the world to offer a targeted blood cancer ...

This 'Forgotten' Blood Test Can Catch Cancer Early first appeared on Parade on Jun 15, 2025 This story was originally ...

Researchers at Johns Hopkins University have discovered that cancer can be detected in the bloodstream a full three years ...

“These results demonstrate that it is possible to detect circulating tumor DNA more than three years prior to clinical ...

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

‘Three years earlier provides time for intervention,’ the lead researcher says of the early detection test. Mr. Curl covered ...

AbbVie (ABBV) stock in focus after a Phase 3 trial setback for leukemia therapy venetoclax marketed with Roche (RHHBY) in ...

A new hereditary condition has been discovered that affects patients' ability to repair DNA – leaving them both at greater ...

Scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a new artificial intelligence (AI)-based ...

The AbbVie-Roche cancer drug venetoclax failed to meet its primary endpoint in a phase 3 trial to treat newly diagnosed ...